Format

Send to

Choose Destination
Cancer Res. 2009 May 1;69(9):4018-26. doi: 10.1158/0008-5472.CAN-08-2641. Epub 2009 Apr 14.

Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation.

Author information

1
Department of Life Science, Research Center for Women's Diseases, Sookmyung Women's University, Seoul, Korea.

Abstract

Low serum levels of adiponectin are a high risk factor for various types of cancer. Although adiponectin inhibits proliferation and metastasis of breast cancer cells, the underlying molecular mechanisms remain obscure. In this study, we show that adiponectin-activated AMPK reduces the invasiveness of MDA-MB-231 cells by stimulating dephosphorylation of AKT by increasing protein phosphatase 2A (PP2A) activity. Among the various regulatory B56 subunits, B56gamma was directly phosphorylated by AMPK at Ser(298) and Ser(336), leading to an increase of PP2A activity through dephosphorylation of PP2Ac at Tyr(307). We also show that both the blood levels of adiponectin and the tissue levels of PP2A activity were decreased in breast cancer patients and that the direct administration of adiponectin into tumor tissues stimulates PP2A activity. Taken together, these findings show that adiponectin, derived from adipocytes, negatively regulates the invasiveness of breast cancer cells by activating the tumor suppressor PP2A.

PMID:
19366811
DOI:
10.1158/0008-5472.CAN-08-2641
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center